Summary:
Understanding tumor heterogeneity is a major challenge that was recognized as one of the first Cancer Grand Challenges, with a call to provide solutions to visualize tumor heterogeneity. The Rosetta team took on this challenge, exploiting advances in spatial-omics approaches centered around mass spectrometry imaging to map tumor heterogeneity at the cellular and molecular scales with different levels of resolution.
See related article by Bressan et al., p. 16
©2025 American Association for Cancer Research
2025
American Association for Cancer Research
You do not currently have access to this content.